Neomycin C

• UNSPSC Description:

  Neomycin C a major active isomeric components of the Neomycin complex. Neomycin, is a 2-DOS-containing aminoglycoside, consisting of neomycin A, neomycin B, and neomycin C. Neomycin C is approximately half as active as neomycin B[1][2].

• Target Antigen:

  Antibiotic

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/neomycin-c.html

• Solubility:

  10 mM in DMSO

• Smiles:

  N[C@@H]1[C@@H](O[C@@H]2[C@H](N)[C@@H](O)[C@H](O)[C@@H](CN)O2)[C@H](O[C@H]3[C@H](O)[C@H](O[C@@H]4[C@H](N)[C@@H](O)[C@H](O)[C@@H](CN)O4)[C@@H](CO)O3)[C@@H](O)[C@H](N)C1

• Molecular Weight:

  614.64

• References & Citations:

  [1]Huang F, et al. Elaboration of neosamine rings in the biosynthesis of neomycin and butirosin. Chembiochem. 2007 Feb 12;8(3):283-8. |[2]Neomycin C. PubChem.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  66-86-4